Genes and pathways underlying regional and cell type changes in Alzheimer's disease.
about
Atypical Rho GTPases of the RhoBTB Subfamily: Roles in Vesicle Trafficking and TumorigenesisBeyond modules and hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disordersTau overexpression impacts a neuroinflammation gene expression network perturbed in Alzheimer's diseaseBuilding an RNA Sequencing Transcriptome of the Central Nervous SystemGenetic variants in Alzheimer disease - molecular and brain network approachesMeta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks.An additional k-means clustering step improves the biological features of WGCNA gene co-expression networks.Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network BiologyProtein homeostasis of a metastable subproteome associated with Alzheimer's disease.Gene expression reversal toward pre-adult levels in the aging human brain and age-related loss of cellular identityIntegrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.PPAR agonists regulate brain gene expression: relationship to their effects on ethanol consumptionCurrent advances in systems and integrative biologyBioinformatics methods in drug repurposing for Alzheimer's disease.Analytical tools and current challenges in the modern era of neuroepigenomicsA shortcut for multiple testing on the directed acyclic graph of gene ontology.Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis.NeuroTransDB: highly curated and structured transcriptomic metadata for neurodegenerative diseases.A new model to study neurodegeneration in ataxia oculomotor apraxia type 2Identifying robust communities and multi-community nodes by combining top-down and bottom-up approaches to clustering.Integrated analysis of genetic, behavioral, and biochemical data implicates neural stem cell-induced changes in immunity, neurotransmission and mitochondrial function in Dementia with Lewy Body mice.Microglial malfunction: the third rail in the development of Alzheimer's disease.Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders.Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer's disease.A transcriptional signature of Alzheimer's disease is associated with a metastable subproteome at risk for aggregationCircuit-wide Transcriptional Profiling Reveals Brain Region-Specific Gene Networks Regulating Depression Susceptibility.Rubidium and potassium levels are altered in Alzheimer's disease brain and blood but not in cerebrospinal fluid.Tetraspanin 6: a pivotal protein of the multiple vesicular body determining exosome release and lysosomal degradation of amyloid precursor protein fragments.Neuroinflammation in Alzheimer's disease: from pathogenesis to a therapeutic target.Moving beyond genetics: is FAM13A a major biological contributor in lung physiology and chronic lung diseases?Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies.Integrated analysis of differential gene expression profiles in hippocampi to identify candidate genes involved in Alzheimer's diseaseNext generation transcriptomics and genomics elucidate biological complexity of microglia in health and disease.Bioinformatics Tools for Genome-Wide Epigenetic Research.Estimation of random effects and identifying heterogeneous genes in meta-analysis of gene expression studies.PRMT1 and PRMT8 regulate retinoic acid-dependent neuronal differentiation with implications to neuropathology.The human-specific CASP4 gene product contributes to Alzheimer-related synaptic and behavioural deficits.Functional Genomic Analyses Identify Pathways Dysregulated in Animal Model of Autism.Towards a Pathway Inventory of the Human Brain for Modeling Disease Mechanisms Underlying Neurodegeneration.Age and Alzheimer's disease gene expression profiles reversed by the glutamate modulator riluzole
P2860
Q26744456-810BE20C-2A84-40EE-936E-92CA7B641FB2Q26830010-351F5755-643A-4F23-BB04-226A32071FA5Q27313627-FDB998C8-1F28-41C7-90A8-5F558D852599Q28066025-528829C0-1CEC-4104-BD7E-BF5DC8B1C53EQ28596011-51F5E5E5-6A99-4DF4-97D9-B486FBE99A60Q31047629-13939A55-58A6-4A13-95AD-E838EFFB0A98Q33555901-34179E44-D45B-479C-AFFC-F875F20C297FQ33734563-F6FE6F8F-E650-4D13-90AF-DCBAD32652D1Q33913554-8299B9F4-5830-4BEB-A4BB-E59B7F34AB63Q33919114-E4158490-8F63-4715-BA8F-95FD2500610EQ34202948-F5D319B6-888C-4211-BEA9-FD3DA94B0183Q34302561-0461C96C-D86A-4AAE-AF7A-B6ED82EFB4C7Q34417712-DDAFCC54-84A7-49E7-8423-0BA08FCD6650Q34486241-49E5D26D-269C-4EEB-A421-B72E5B2F4707Q34670822-7D907126-D9B2-451F-B8E4-946C6F6F6889Q35389826-EBAD5F27-7831-413B-BC4D-496134E7ECFCQ35810427-7F2F4A1B-F108-43B9-A757-8D8611E348FCQ35811161-71ECB3AA-D69E-4201-AA4C-8C7F70FD991CQ36089379-53B73DBC-BC2D-474E-8939-BC019C4A4380Q36262362-BCDB5ABE-25CE-4679-AE16-9BE8AA32EAD6Q36304737-85BA4449-3976-4B2C-B92E-848B95A602B0Q36348184-0069E173-7F6E-4F53-87FF-893708CC6473Q36424672-EECD7E1C-4D7B-4A8F-94D4-9D9008EAE0F5Q36481711-3BE9E595-BEC7-4E95-9980-A4FD14222552Q36866261-30962CD1-31CB-464E-9CB3-21430168BF28Q36978291-B3FECA0D-8011-42AF-BEA1-A0E6368A2F47Q37414532-D82BE639-AA55-48D5-9C31-A76B22D4EC5BQ37692628-E7A98C2C-D2FE-4062-9BE6-3016494A0608Q38202910-DA497311-92BD-4A0F-A2F5-C2ED29CAB098Q38243943-EEC194E2-9105-48A8-8032-0C84E65D5DF4Q38435692-D6E828B4-710E-4BB8-A4A1-8BDB0DB6A826Q38458442-4BB4ED88-EE33-46BF-BC9F-778AEEEB066EQ38514940-5DA5F696-2E5E-4D3F-B80D-73235E7EAF22Q38775538-BACF8B97-B4E0-490D-8283-1CD7344DFC0AQ38877541-FE99ABF4-39EA-4897-8572-711DBAEF811AQ38941212-F27FB3A0-3EA2-4635-AC9E-61301F3F841CQ39497033-4C607E51-083F-4462-8D35-7345E4E83610Q39671363-264DAF5A-F86C-45FE-8737-1F79259FF0C7Q39850175-9BD9AB61-5654-45C0-AC08-B38707BF3394Q39883358-5CD1B314-1AD8-4268-A024-5F0752CD9E0F
P2860
Genes and pathways underlying regional and cell type changes in Alzheimer's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Genes and pathways underlying regional and cell type changes in Alzheimer's disease.
@en
type
label
Genes and pathways underlying regional and cell type changes in Alzheimer's disease.
@en
prefLabel
Genes and pathways underlying regional and cell type changes in Alzheimer's disease.
@en
P2093
P2860
P356
P1433
P1476
Genes and pathways underlying regional and cell type changes in Alzheimer's disease.
@en
P2093
Daniel H Geschwind
Jeff M Goodenbour
Jeremy A Miller
Steve Horvath
P2860
P2888
P356
10.1186/GM452
P577
2013-05-25T00:00:00Z
P5875
P6179
1044350050